<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ESOMEPRAZOLE MAGNESIUM</span><br/>(e-so-me'pra-zole)<br/><span class="topboxtradename">Nexium<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">proton pump inhibitor</span><br/><b>Prototype: </b>Omeprazole<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>20 mg, 40 mg capsules; 20 mg, 40 mg powder for injection</p>
<h1><a name="action">Actions</a></h1>
<p>Isomer of omeprazole. A weak base that is converted to the active form in the highly acidic environment of the secretory surface
         of the gastric parietal cells. Inhibits the enzyme H<sup>+</sup>K<sup>+</sup>-ATPase (the acid pump).
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Due to inhibition of the H<sup>+</sup>K<sup>+</sup>-ATPase, esomeprazole substantially decreases both basal and stimulated acid secretion through inhibition of the acid pump
         in parietal cells.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Erosive esophagitis, gastrointestinal reflux disease (GERD), duodenal ulcer associated with <i>H. pylori</i> in combination with antibiotics.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to esomeprazole magnesium, omeprazole, or other proton pump inhibitors; gastric malignancy; lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Severe renal insufficiency; sever hepatic impairment; treatment for more than a year; gastric ulcers; pregnancy (category
         C). Safety and efficacy in children are not established.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Healing of Erosive Esophagitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO or IV</span> 2040 mg q.d. at least 1 h before meals times 48 wks<br/><br/><span class="indicationtitle">GERD, Erosive Esophagitis Maintenance</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 20 mg q.d.<br/><br/><span class="indicationtitle">Duodenal Ulcer</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 40 mg q.d. times 10 d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give at least 1 h before eating.</li>
<li>Do not crush or chew capsule. Must be swallowed whole.</li>
<li>Open capsule and mix pellets with applesauce (cold or room temperature) if patient cannot swallow capsules. Do <small>NOT</small> crush pellets. Applesauce should be swallowed immediately after mixing without chewing.
         </li>
<li>May take with antacids.</li>
<li>Store in the original blister package 15°30° C (59°86° F).</li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span> Reconstitute powder with 5 mL of NS.  <span class="methodtype">IV Infusion:</span> Further dilute reconstituted solution in 50 mL of NS, LR, or D5W.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span> Withdraw 5 mL of reconstituted solution and give over no less than 3 min.  <span class="methodtype">IV Infusion:</span> Give IV solution over 1030 min.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> Do not give simultaneously with any other medication through the same IV site or line. Flush IV line with NS, LR, or D5W before/after
                  infusion. 
               </p>
</td>
</tr>
</table>
<ul>
<li>Store reconstituted solution at room temperature up to 30° C (86° F); give within 12 h of reconstitution with NS
            or LR and within 6 h of reconstitution with D5W.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Headache. <span class="typehead"> GI:</span> Nausea, vomiting, diarrhea, constipation, abdominal pain, flatulence, dry mouth. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May increase <b>diazepam,</b>
<b>phenytoin,</b>
<b>warfarin</b> levels. <span class="typehead">Food:</span> Food decreases absorption by up to 35%. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Destroyed in acidic environment, therefore capsules are designed for delayed absorption in the small intestine. 70% reaches
      systemic circulation. <span class="typehead">Metabolism:</span> Metabolized in liver by CYP2C19. <span class="typehead">Elimination:</span> Inactive metabolites excreted in both urine and feces. <span class="typehead">Half-Life:</span> 1.5 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of adverse CNS effects (vertigo, agitation, depression) especially in severely ill patients.</li>
<li>Monitor phenytoin levels with concurrent use.</li>
<li>Monitor INR/PT with concurrent warfarin use.</li>
<li>Lab tests: Periodic liver function tests, CBC, Hct &amp; Hbg, urinalysis for hematuria and proteinuria.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report any changes in urinary elimination such as pain or discomfort associated with urination to physician.</li>
<li>Report severe diarrhea. Drug may need to be discontinued.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>